MARMO-AD | Jan 30, 2024 12:00 PM EST

Drs. Afonso Silva and Stacey Rizzo will introduce MARMO-AD, a new Open Science consortium that is studying gene-edited marmoset models carrying genetic risk for Alzheimer’s disease (AD) and wild-type genetically diverse aging marmosets from birth throughout their lifespan, using non-invasive longitudinal assessments. These include characterizing the genetic, molecular, functional, behavioral, cognitive, and pathological features of aging and AD. The goals of MARMO-AD are to bridge the rodent to human translational gap by investigating primate-specific mechanisms that contribute to the pathogenesis of AD, as well as utilize the sophisticated behavioral repertoire and higher order cognitive functions of the marmosets to evaluate the efficacy of novel therapeutics with the potential to treat and prevent AD and related dementias. Registration for this webinar is now available.